Humana declares quarterly dividend of $0.885 per share

LOUISVILLE - Health insurer Humana Inc. (NYSE:HUM), with a market capitalization of $35.46 billion, announced Thursday that its Board of Directors has declared a quarterly cash dividend of $0.885 per share. The dividend will be payable on October 31, 2025, to stockholders of record as of the close of business on September 26, 2025. This continues the company’s 15-year track record of consistent dividend payments, with the current yield standing at 1.22%.

The dividend announcement represents Humana’s ongoing commitment to returning value to shareholders. The company, which provides insurance services and healthcare services through its CenterWell division, serves millions of people with Medicare, Medicaid, families, individuals, military service personnel, and communities. According to InvestingPro data, Humana maintains strong financial health with annual revenues of $123.11 billion and holds more cash than debt on its balance sheet.

Humana focuses on making healthcare more accessible by delivering care and services when needed. The company’s operations span both insurance and direct healthcare delivery sectors.

The dividend declaration was disclosed in a company press release issued Thursday.

In other recent news, Humana reported a strong second quarter for 2025, exceeding analysts’ expectations with an earnings per share (EPS) of $6.27. This figure was higher than the projected $5.87, showcasing a solid performance. The company also surpassed revenue forecasts, posting $32.39 billion compared to the anticipated $31.85 billion. Raymond James reiterated its Outperform rating on Humana stock, maintaining a $340 price target following these impressive results. The insurance medical loss ratio was reported at 89.9%, aligning with Street expectations and slightly outperforming Raymond James’ estimate of 90.0%. RBC Capital raised its price target for Humana to $322 from $283, citing a stars bonus recovery and maintaining an Outperform rating. These developments reflect positive sentiment from analysts regarding Humana’s recent performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.